?????? ?? ???? ?? ???? ????? ?? ?? ? ...

1.
2006 Vol. 33, No. 1(A)
, , ,
.
, ,
3
3~5 [1]. 20
25%, 50 45%
,
, 20%
.
,
[1].
(Bayesian network, BN)
[2].
.
,
[2-4].
.
,
.
.
,
CooperHerskovitzK2
[5]. K2
[6].
O
sammy@sclab.yonsei.ac.kr O
sbcho@cs.yonsei.ac.kr
An Attribute Ordering Optimization in Bayesian Networks for Prognostic Modeling
of the Metabolic
Syndrome
Han-Saem Park ,O and Sung-Bae Cho
Dept. of Computer Science, Yonsei University
, , , ,
.
.
K2 ,
.
. 1993
1995
, k-.
, .
,
.
2.
2.1.
National Cholesterol Education Panel (NCEP)Adult Treatment
Panel (ATP) III 53
[1].
1) : >102 cm (>40 in), >88 cm
(>35 in),
2) (hypertriglyerides): =150 mg/dL,
3) HDL (low high-density lipoprotein cholesterol):

3.
1 .
, , BN ,
.
,
.
1.
3.1.
.
[1],
.
,
110 normal 110 ~ 125
impaired glucose metabolism, 126diabetes
. 150 200
increased () 150
. HDL
. 40,
50 decreased (HDL).
[1].
3.2.
2006 Vol. 33, No. 1(A)
K2
, K2
. Larranaga TSP (Traveling
Salesman Problem),
[6].
,
GA
.
1)
1, .
.
[1].
(, , ),
(, 2, ,
HDL ),
.
7.
,
.
2)
2.
2. m
, ID,
, .
.
.
p(
g,j)
n Rank(
f ( I(
g,j)
)) 1
n(
n 1)
/ 2
. (1)
gj,
. ,
.
3.
. Larranaga
TSP
(Cycle Crossover Operator).
.
3.
4.
(Displacement mutation
operator)Larranaga

[6].
,
. 4
.
3)
,
. K2
[5],
.
4.
4.1.
. 1993 2520
2293 1 , 1995
2 1193[7]. ,
,
,
Modified NCEP-ATP III
. 1193
1135 ,
18 . 18,
, , 2, , ,
, , , GOT, GPT, , ,
HDL , , -, ,
.
(Neural
Network, NN) k (k-nearest neighbors, kNN)
. 11-20-2-
-kNNk
3.
20100. 0.8
, 0.02, 1.0,
1 .
10-fold cross validation 30
, 3:1:1 ,
, .
4.2.
8,
11,
18 .
1 11
. (p

2006 Vol. 33, No. 1(A)

2006 Vol. 33, No. 1(A)

2006 Vol. 33, No. 1(A)

2006 Vol. 33, No. 1(A)

2006 Vol. 33, No. 1(A)

2006 Vol. 33, No. 1(A)

2006 Vol. 33, No. 1(A)

2006 Vol. 33, No. 1(A)

2006 Vol. 33, No. 1(A)

2006 Vol. 33, No. 1(A)